North America Organ Preservation Solutions Market Forecast to 2028

North America Organ Preservation Solutions Market Forecast to 2028

North America Organ Preservation Solutions Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, and Others], Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)

Send Enquiry
Item ID: TIPRE00025778 Category: Tag:

$2,100 – $3,500

Description

The North America organ preservation solutions market is expected to grow from US$ 120.36 Million in 2023 to US$ 177.18 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.

Increasing Prevalence of Chronic Diseases Leading to Kidney Failure Fueling North America Organ Preservation Solutions Market Growth

A kidney transplant is the most common organ transplant globally. According to the Organ Procurement and Transplantation Network (OPTN), in 2021, 41,354 organ transplants were performed in the US, an increase of 5.9% over 2020. There were a total of 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants.

Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately one in every ten people worldwide. Additionally, a study published by the National Kidney Foundation predicted that the diabetic population over the age of 20 would develop chronic kidney disease over time.

The National Kidney Foundation reported that CKD is expected to kill more people in 2021 than prostate or breast cancer. It is a widely under-recognized emergency health condition.

According to the estimates given by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. According to the CDC report issued in 2021, ~15% of people in the US suffer from chronic renal disease each year.

The National Kidney Foundation states that people with kidney damage are unaware of having chronic kidney disease, which indicates the underlying market potential in the kidney disease market. These factors are expected to enhance market growth during the forecast period.

North America Organ Preservation Solutions Market Overview

The North America organ preservation solution market is analyzed based on three major countries: the US, Canada, and Mexico. The US holds the largest share of the organ preservation solution market owing to factors such as the increasing organ transplantation and growing geriatric population.

In North America, the US is the largest market for organ preservation solutions. Increasing prevalence of chronic kidney diseases and growing geriatric population in the US are likely to accelerate the development of this market. For instance, according to the National Chronic Kidney Disease fact sheet, in 2021, ~37 million people had chronic kidney diseases in the US. Furthermore, according to the American Kidney Fund, Inc, ~810,000 Americans have kidney failure, of which 570,000 patients are undergoing dialysis, and 240,000 have undergone kidney transplantation. In addition, according to the CDC, chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%) with respect to the current estimate. Moreover, with the increasing prevalence of CKD in the US, CKD-related health problems worsen over time. It also increases the chances of having heart disease and stroke. Thus, owing to these facts, the cases of kidney transplantations are likely to increase in the coming years. Moreover, the rise in FDA approvals and the presence of the major market players in the region are boosting the market growth. For instance, in April 2022, TransMedics Group, Inc. received premarket U.S. Food and Drug Administration (FDA) approval of its OCS Heart System for use with organs from donors after circulatory death (DCD).

North America Organ Preservation Solution Market Revenue and Forecast to 2028 (US$ Million)

North America Organ Preservation Solution Market Segmentation

The North America organ preservation solution market is segmented into type, application, organ type, end user, and country.

Based on type, the North America organ preservation solution market is segmented into University of Wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The University of Wisconsin solution segment registered the largest North America organ preservation solution market share in 2023.

Based on application, the North America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest North America organ preservation solution market share in 2023.

Based on organ type, the North America organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest North America organ preservation solution market share in 2023.

Based on end user, the North America organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest North America organ preservation solution market share in 2023.

Based on country, the North America organ preservation solutions market has been categorized into the US, Canada, and Mexico. The US dominated the North America organ preservation solutions market share in 2023.

21ST CENTURY MEDICINE; Accord Healthcare; Bridge to Life Ltd; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; OrganOx Limited; Paragonix Technologies, Inc; Preservation Solutions, Inc.; TransMedics; Waters Medical Systems LLC; and XVIVO Perfusion are the leading companies operating in the North America organ preservation solutions market in the region.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 8.0% CAGR, the North America Organ Preservation Solutions Market is speculated to be worth US$ 177.18 Million by 2028, says the research team
According to the research team’ research, the North America organ preservation solutions market was valued at US$ 120.36 Million in 2023 and is expected to reach US$ 177.18 Million by 2028, registering a CAGR of 8.0% from 2023 to 2028. Rising need for organ transplantation and increasing prevalence of chronic diseases leading to kidney failure are the critical factors attributed to the North America organ preservation solutions market expansion.
Organ transplantation is a surgical procedure used when a patient’s organ no longer functions properly. Organ transplantation is most for heart, liver, and kidney. However, the rising prevalence of chronic diseases is necessitating organ transplantation for organs such as the lung, pancreas, cornea, and vascular tissues. Organ transplantation is regarded as one of the most significant advances in modern medicine.
Rise in chronic diseases that cause damage to the functions of the heart, lung, liver, kidney, and other organs is leading to an increase in the number of organ transplants. Moreover, excessive alcohol consumption leads to liver cirrhosis and ultimately needs liver transplant and a poor diet contribute to the development of renal and hepatic illnesses, which can lead to organ failure. This is yet another factor contributing to the growth of the organ transplantation and therefore preservation solutions market. Transplantation surgeries are becoming more common around the world.
The public-private partnership in collaboration with transplant coordinators has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries have seen an increase in the number of organ transplant surgeries.
According to the U.S. Department of Health & Human Services, in 2021, more than 1 in 7, that is 15% of US adults, approximately 37 million people are estimated to have chronic kidney disease. As a result, the rising incidence of chronic kidney diseases is likely to increase the demand for kidney transplantation in the coming years, which boosts the need for solutions to keep the organs in a healthy condition. Similarly, it is expected that the rising cases of heart diseases will drive the market in the coming years.
On the contrary, expensive organ transplant surgeries hurdles the growth of North America organ preservation solutions market.
Based on type, the North America organ preservation solutions market is segmented into University of Wisconsin solution, custodiol HTK, perfadex, hypothermosol, and others. The University of Wisconsin solution segment held 36.5% share of North America organ preservation solutions market in 2023, amassing US$ 43.94 Million. It is projected to garner US$ 65.04 Million by 2028 to expand at 8.2% CAGR during 2023–2028.
Based on application, the North America organ preservation solutions market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held 45.7% share of North America organ preservation solutions market in 2023, amassing US$ 55.02 Million. It is projected to garner US$ 81.66 Million by 2028 to expand at 8.2% CAGR during 2023–2028.
Based on organ type, the North America organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held 59.2% share of North America organ preservation solutions market in 2023, amassing US$ 71.25 Million. It is projected to garner US$ 105.82 Million by 2028 to expand at 8.2% CAGR during 2023–2028.
Based on end user, the North America organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics, The organ transplant centers segment held 57.5% share of North America organ preservation solutions market in 2023, amassing US$ 69.23 Million. It is projected to garner US$ 103.49 Million by 2028 to expand at 8.4% CAGR during 2023–2028.
Based on country, the North America organ preservation solutions market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.3% share of North America organ preservation solutions market in 2023. It was assessed at US$ 100.23 Million in 2023 and is likely to hit US$ 149.04 Million by 2028, exhibiting a CAGR of 8.3% during the forecast period.
Key players dominating the North America organ preservation solutions market are 21ST CENTURY MEDICINE; Accord Healthcare; Bridge to Life Ltd; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; OrganOx Limited; Paragonix Technologies, Inc; Preservation Solutions, Inc.; TransMedics; Waters Medical Systems LLC; and XVIVO Perfusion among others.
In Aug 2022, Paragonix Technologies, Inc. announced a significant milestone of preserving over 2,000 donor organs while also providing transplant hospitals with Advanced Organ Preservation (AOPT) technology and a statewide clinical support network. Each of these technologies employs first-of-their-kind preservation methods and has proven to improve conventional ice and cooler practices significantly. In Dec 2021, OrganOx received the U.S. Food and Drug Administration (FDA) premarket approval (PMA) of its metra system. The OrganOx metra is a fully automated NMP device for preserving and transporting donor livers destined for transplantation. The marketing approval includes both livers from donors after brain death (DBD) and livers from donors after circulatory death (DCD).

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America organ preservation solution market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the North America organ preservation solution market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the organ preservation solution market as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 North America Organ Preservation Solution Market – by Type
1.3.2 North America Organ Preservation Solution Market – by Application
1.3.3 North America Organ Preservation Solution Market – by Organ Type
1.3.4 North America Organ Preservation Solution Market – by End User
1.3.5 North America Organ Preservation Solution Market – by Country
2. North America Organ Preservation Solution Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Organ Preservation Solution Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinions
5. North America Organ Preservation Solution Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Need for Organ Transplantation
5.1.2 Increasing Prevalence of Chronic Diseases Leading to Kidney Failure
5.1.3 Rising Geriatric Population
5.2 Market Restraints
5.2.1 Expensive Organ Transplant Surgeries
5.2.2 Limited Number of Donors for Organ Transplant Surgeries
5.3 Market Opportunities
5.3.1 Rising Prevalence of Cardiovascular Diseases (CVDs)
5.4 Future Trends
5.4.1 Growth Opportunities in Emerging Nations
5.5 Impact Analysis
6. Organ Preservation Solution Market – North America Analysis
6.1 North America Organ Preservation Solutions Market Revenue Forecast and Analysis
7. North America Organ Preservation Solution Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.1.1 North America Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
7.2 University of Wisconsin Solution (UW) Market
7.2.1 Overview
7.2.2 University of Wisconsin solution (UW) :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
7.3 Custodiol HTKs
7.3.1 Overview
7.3.2 Custodiol HTKs :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
7.4 Perfadex
7.4.1 Overview
7.4.2 Perfadex : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
7.5 Hypothermosol
7.5.1 Overview
7.5.2 Hypothermosol : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
7.6 Others
7.6.1 Overview
7.6.2 Others : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
8. North America Organ Preservation Solution Market – Revenue and Forecast to 2028 – by Application
8.1 Overview
8.2 North America Organ Preservation Solutions Market Share, by Application, 2022 and 2028 (%)
8.3 Static Cold Storage
8.3.1 Overview
8.3.2 Static Cold Storage: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
8.4 Hypothermic Machine Perfusion
8.4.1 Overview
8.4.2 Hypothermic Machine Perfusion: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
8.5 Normothermic Machine Perfusion
8.5.1 Overview
8.5.2 Normothermic Machine Perfusion: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
8.6 Others
8.6.1 Overview
8.6.2 Others: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
9. North America Organ Preservation Solution Market – Revenue and Forecast to 2028 – by Organ Type
9.1 Overview
9.2 North America Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
9.3 Heart
9.3.1 Overview
9.3.2 Heart: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
9.4 Lung
9.4.1 Overview
9.4.2 Lung: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
9.5 Kidney
9.5.1 Overview
9.5.2 Kidney: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
9.6 Liver
9.6.1 Overview
9.6.2 Liver: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
9.7 Others
9.7.1 Overview
9.7.2 Others: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
10. North America Organ Preservation Solution Market – Revenue and Forecast to 2028 – by End User
10.1 Overview
10.2 North America Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
10.3 Organ Transplant Centres
10.3.1 Overview
10.3.2 Organ Transplant Centres : North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
10.4 Hospitals
10.4.1 Overview
10.4.2 Hospitals: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
11. North America Organ Preservation Solution Market – Revenue and Forecast to 2028 –Country Analysis
11.1 North America: Organ Preservation Solution Market
11.1.1 Overview
11.1.1.1 United States: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.1.1.1 Overview
11.1.1.1.2 United States: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.1.1.3 United States: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.1.1.4 United States: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.1.1.5 United States: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.1.1.6 United States: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
11.1.1.2 Canada: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.1.2.1 Overview
11.1.1.2.2 Canada: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.1.2.3 Canada: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.1.2.4 Canada: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.1.2.5 Canada: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.1.2.6 Canada: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
11.1.1.3 Mexico: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.1.3.1 Overview
11.1.1.3.2 Mexico: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.1.3.3 Mexico: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.1.3.4 Mexico: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.1.3.5 Mexico: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.1.3.6 Mexico: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
12. North America Organ Preservation Solution Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Organ Preservation Solutions Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Waters Medical Systems LLC
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 XVIVO Perfusion
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 TransMedics
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 OrganOx Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Paragonix Technologies, Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Dr. Franz Koehler Chemie GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Accord Healthcare
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8ST CENTURY MEDICINE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bridge to Life Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Preservation Solutions, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Lifeline Scientific, Inc.
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1. United States Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 2. United States Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. United States Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 4. United States Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Canada Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Mexico Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Mexico Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
Table 14. Recent Organic Growth Strategies in the Organ Preservation Solutions Market
Table 15. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Organ Preservation Solution Market Segmentation
Figure 2. North America Organ Preservation Solution Market, by region
Figure 3. North America Organ Preservation Solution Market Overview
Figure 4. University of Wisconsin solution (UW) Segment Held Largest Share of Type Segment in North America Organ Preservation Solution Market
Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Organ Preservation Solutions Market Impact Analysis of Drivers and Restraints
Figure 8. North America Organ Preservation Solutions Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
Figure 10. University of Wisconsin solution (UW) :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 11. Custodiol HTKs :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 12. Perfadex : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 13. Hypothermosol : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 14. Others: North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 15. Medical devices market Share, by Application, 2022 and 2028 (%)
Figure 16. Static Cold Storage: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 17. Hypothermic Machine Perfusion: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 18. Normothermic Machine Perfusion: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 19. Others: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 20. North America Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
Figure 21. Heart: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 22. Lung: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 23. Kidney: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 24. Liver: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 25. Others: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 26. North America Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
Figure 27. Organ Transplant Centers: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 28. Hospitals: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 29. Specialty Clinics: North America Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 30. North America: Organ Preservation Solution Market, by Key Country – Revenue (2022) (US$ Thousand)
Figure 31. North America: Organ Preservation Solution Market, by Country, 2022 & 2028 (%)
Figure 32. United States: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 33. Canada: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 34. Mexico: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 35. Growth Strategies in the Organ Preservation Solutions Market

The List of Companies – Organ Preservation Solutions Market
o 21ST CENTURY MEDICINE
o Accord Healthcare
o Bridge to Life Ltd
o Dr. Franz Koehler Chemie GmbH
o Lifeline Scientific, Inc
o OrganOx Limited
o Paragonix Technologies, Inc
o Preservation Solutions, Inc.
o TransMedics
o Waters Medical Systems LLC
o XVIVO Perfusion

Reviews

There are no reviews yet.

Be the first to review “North America Organ Preservation Solutions Market Forecast to 2028”